ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 649270 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 649270; 2) Community: the network communities that were significantly associated with the response to NSC 649270; 3) Molecule: the relationships between components within communities and NSC 649270; 4) MDR: the compounds that were significantly associated with the NSC 649270.

NSC Compound Enrichment Correlation
NSC 718781 Erlotinib hydrochloride 0.0329129886465387 0.43653304
NSC 720495 Null 0.0329129886465387 0.11449916
NSC 725098 Null 0.0329129886465387 -0.33813935
NSC 744688 Null 0.0329129886465387 -0.24521394
NSC 752278 2,7-Bis-[2-(2,3,4-trimethoxy-benzylamino)-ethyl]-benzo[lmn][3,8]phenanthroline-1,3,6,8-tetraone di-p-toluensulfonate salt 0.0329129886465387 -0.26072723
NSC 753377 3-[2-(1-methyl-1H-indol-3-yl)-1,3-thiazol-4-yl]-1-methyl-1H-pyrrolo[2,3-b]pyridine 0.0329129886465387 -0.1199484
NSC 753456 2-4-[5-(3,5-dimethoxyphenyl)-1H-1-imidazolyl]phenyl-5,6,7-trimethoxy-1,3-benzothiazole 0.0329129886465387 -0.045272167
NSC 753661 methyl ester prodigiosene 0.0329129886465387 -0.38755365
NSC 761822 (Z)-3-((1-(4-fluorophenyl)-9H-pyrido[3,4-b]indol-3-yl)methylene)-5-methoxyindolin-2-one 0.0329129886465387 -0.29223867
NSC 11232 Anisole-2-azo-.beta.-naphthol 0.0329129886465389 0.30473317
Total:94  Current:69    [First] [Prev] [Next] [Last]